Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Eisai CO Ltd ADR (ESALY)

Eisai CO Ltd ADR (ESALY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Xencor (XNCR) Jumps: Stock Rises 7.4%

Xencor (XNCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

ESALY : 50.2750 (-0.29%)
XNCR : 34.81 (-5.69%)
The Zacks Analyst Blog Highlights: Eisai, Martin Marietta and Columbia Sportswear

The Zacks Analyst Blog Highlights: Eisai, Martin Marietta and Columbia Sportswear

COLM : 95.38 (-0.26%)
ESALY : 50.2750 (-0.29%)
MLM : 266.85 (+0.17%)
Ocular (OCUL) Gets FDA Nod for Label Expansion of Dextenza

Ocular (OCUL) clinches the FDA approval for the label expansion of Dextenza to treat ocular inflammation following ophthalmic surgery.

ESALY : 50.2750 (-0.29%)
AERI : 23.40 (+0.30%)
REGN : 294.70 (-0.40%)
OCUL : 4.06 (-1.93%)
Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint

Ocular's (OCUL) phase III study on OTX-TP for the reduction of intraocular pressure (IOP) in patients with primary open-angle glaucoma fails to achieve primary endpoint.

ESALY : 50.2750 (-0.29%)
AERI : 23.40 (+0.30%)
PFE : 36.24 (-1.23%)
OCUL : 4.06 (-1.93%)
Catalent Acquires Gene Therapy Leader Paragon Bioservices

Catalent (CTLT) acquires gene therapy leader Paragon Bioservices for $1.2 billion.

ESALY : 50.2750 (-0.29%)
CTLT : 51.56 (-0.08%)
REPH : 11.87 (+0.25%)
EVTCY : 45.6000 (-0.63%)
CannTrust Holdings (CTST) in Focus: Stock Moves 6.1% Higher

CannTrust Holdings (CTST) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

ESALY : 50.2750 (-0.29%)
CTST : 1.29 (-1.53%)
Catalyst (CPRX) Q1 Loss Narrows, Firdapse Off to a Good Start

Catalyst (CPRX) posts narrower-than-expected loss and beats on revenues in the first quarter of 2019.

ESALY : 50.2750 (-0.29%)
CPRX : 5.51 (-16.77%)
REPH : 11.87 (+0.25%)
BSTC : 58.13 (+0.66%)
Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss

Zoetis???s (ZTS) earnings beat estimates but sales miss the same in the first quarter of 2019.

ESALY : 50.2750 (-0.29%)
ZTS : 125.08 (-0.43%)
FGEN : 40.84 (+2.36%)
BSTC : 58.13 (+0.66%)
Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65%

Achaogen (AKAO) files for bankruptcy in a district court. Shares slump 65% on the announcement.

ESALY : 50.2750 (-0.29%)
AKAO : 0.11 (unch)
ASRT : 1.38 (unch)
BSTC : 58.13 (+0.66%)
Zogenix Gets Refusal to File Letter From FDA for Seizure Drug

Zogenix (ZGNX) receives a Refusal to File letter from the FDA regarding its NDA for Fintepla for the treatment of seizures associated with Dravet syndrome.

ESALY : 50.2750 (-0.29%)
GWPH : 126.49 (-1.88%)
ZGNX : 42.29 (+2.08%)
BSTC : 58.13 (+0.66%)
United Therapeutics Discontinues PAH Drug After Study Fails

United Therapeutics (UTHR) discontinues the development of esuberaprost, as the phase III study fails to meet primary endpoint.

ESALY : 50.2750 (-0.29%)
LLY : 114.18 (-1.70%)
UTHR : 85.08 (-1.06%)
BSTC : 58.13 (+0.66%)
Why Eisai (ESALY) Could Be an Impressive Growth Stock

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Eisai (ESALY).

ESALY : 50.2750 (-0.29%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
AIZ -0.80 , WELL +0.26 , SBAC -1.20 , CCI +0.86 , SO +0.21
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar